A groundbreaking annual injection designed to protect against HIV has successfully passed its first safety trial, bringing new hope for long-term prevention.

Up to 80 percent of Uganda’s HIV/Aids response is funded by external donors such as the US government and the Global Fund. The funds have been covering majorly the purchase of antiretroviral drugs and ...

The university, a leader in scientific research, has been hard hit by the Trump administration’s cuts, which will slash at ...

Aid cuts by the United States are hurting Africa's capacity to respond to disease outbreaks, the head of the continent's ...

USAID was the pace-setter on locally led development," says Moses Isooba of the Uganda National NGO Forum. But now that it has stepped back, localization efforts and funding are likely to decline.